HOME >> MEDICINE >> NEWS
Promising drug fails to thwart fatal lung disease in large trial

DURHAM, N.C. -- A treatment that had shown early promise in alleviating symptoms and preventing the advance of the fatal lung disease pulmonary fibrosis failed to stall the disorder's progression in 162 patients, according to the results of an international clinical trial reported in the Jan. 8, 2004, issue of The New England Journal of Medicine.

Despite the treatment's failure to prevent scarring of the lungs -- a defining characteristic of the disease -- results of the trial did suggest that the drug, known as interferon gamma-1b, might extend the lives of select patients with mild to moderate symptoms, said pulmonologist David A. Schwartz, M.D., who led a portion of the trial at Duke University Medical Center.

"The bottom-line is that interferon gamma does not appear to be effective in slowing progression of pulmonary fibrosis (PF), but could potentially improve survival in patients if caught early in the disease process," Schwartz said.

The study was funded by InterMune Pharmaceuticals, Inc, Brisbane, CA, which manufactures interferon gamma-1b. Dr. Schwartz has been a paid consultant for InterMune since 2000.

PF is an inflammatory disease that results in scarring, or fibrosis, of the lungs. Over time, the fibrosis can progress such that the lungs can no longer deliver oxygen to the body's tissues. Although physicians often treat the disorder with a combination of anti-inflammatory and immunosuppressive therapies, the only clearly effective treatment is lung transplantation, Schwartz said. The median survival time for patients with the disease is two to three years.

PF has multiple causes including exposure to environmental contaminants, such as cigarette smoke and asbestos, and genetic predisposition. The prevalence of the disease is unknown according the National Institutes of Health, but estimates indicate the numbers are rising with as many as 15,000 new cases of idiopathic PF -- a form of the disease having unkno
'"/>

Contact: Kendall Morgan
kendall.morgan@duke.edu
919-684-4148
Duke University Medical Center
7-Jan-2004


Page: 1 2 3

Related medicine news :

1. Promising new strategy for Swedish medical research
2. Promising treatments for Huntingtons disease identified in UCI study
3. Promising results for malaria vaccine trial
4. Promising diagnostic test for sleeping sickness
5. Promising new treatment options for people with co-existing alcohol-use and psychiatric disorders
6. Promising drug proves ineffective as treatment for hearing loss
7. Promising West Nile virus vaccine protects monkeys
8. Promising new treatment preserves bone mass in mice; May help women and men with osteoporosis
9. Promising vaccine may provide long-lasting protection against malaria
10. Promising new research on schizophrenia causes
11. UI Study Suggests Promising Treatment For Diabetic Pregnancies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2018)... (PRWEB) , ... September 24, 2018 , ... ... an aromatherapy shower tablet diffuser, which offers eight scents infused with essential oils ... is a completely new-to-the-world product. It is the first device designed to let ...
(Date:9/24/2018)... ... 2018 , ... On Sunday, October 21, 2018, the Damon Runyon Cancer Research ... climb at the new Salesforce Tower in San Francisco, to raise funds for innovative ... expected to take part in this unique vertical challenge, the first fundraising stair climb ...
(Date:9/24/2018)... ... 2018 , ... Paris-based My Cuistot is dedicated ... of talented chefs works constantly to create innovative, balanced meals, which are delivered ... standard weekly meals, My Cuistot is happy to customize its meal deliveries for ...
(Date:9/22/2018)... ... 2018 , ... From 1991 to 2012, Works of Heart raised more than ... all thanks to the generous artists, sponsors, and patrons who supported what became the ... response to HIV/AIDS, about the Alliance of AIDS Services - Carolina, and (now) about ...
(Date:9/22/2018)... ... September 22, 2018 , ... The health risks associated with heart disease, ... particularly affects older adults – the risk of injury due to falling. , According ... and adult aged 65 and older falls in the United States. Every 12 seconds, ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... ... , ... "As of Thursday, Sept. 13, 2018, Cedar Point, North Carolina, where ... this Women of Influence tour with the knowledge that my home will have some ... hold onto my faith through this storm. So many lives are being affected by ...
(Date:9/13/2018)... ... September 13, 2018 , ... ... now available to test and ensure correct implementation of the NCPDP SCRIPT Standard ... 2017071 includes important functionality and transactions identified by the industry as vital enhancements ...
(Date:9/12/2018)... ... September 12, 2018 , ... Surgical Theater will ... IL, from September 19-22. The IT + Revenue Cycle Conference provides Surgical Theater ... with the use of Precision Virtual Reality™ medical visualization platform. This 360VR technology ...
Breaking Medicine Technology:
Cached News: